German pharmaceuticals giant Bayer has agreed to buy American GMO company Monsanto for $128 a share. The acquisition values Monsanto’s equity at about $56 billion, but including debt the deal is worth nearly $66 billion….
The Best in Alternative News
German pharmaceuticals giant Bayer has agreed to buy American GMO company Monsanto for $128 a share. The acquisition values Monsanto’s equity at about $56 billion, but including debt the deal is worth nearly $66 billion….